Although L654 is a TLR2 ligand, in a 2013 study of serum L654 in patients with multiple sclerosis (MS), we postulated that L654 was functioning as an immune regulator rather than as an immune stimulator (13). The gene discussed is TLR2; the disease is myeloid sarcoma.